0R15 8539.0 2.1534% 0R1E 8600.0 3.3654% 0M69 None None% 0R2V 190.25 -0.1312% 0QYR 1345.5 2.0871% 0QYP 424.0 0.5931% 0LCV 146.6464 -1.3147% 0RUK None None% 0RYA 1631.0 -0.6094% 0RIH 171.3 0.9131% 0RIH 174.9 2.1016% 0R1O 186.0 9820.0% 0R1O None None% 0QFP None None% 0M2Z 298.3 -0.6495% 0VSO None None% 0R1I None None% 0QZI 474.5 0.6363% 0QZ0 220.0 0.0% 0NZF None None%
Last update at 2024-05-16T15:35:00Z
| Breakdown |
|---|
| Breakdown |
|---|
| Breakdown |
|---|
Sector: Healthcare Industry: Medical Devices
| Company | Change (GBP) | Price (GBP) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| NIOX NIOX Group PLC |
1.00 1.35% | 75.00 | 32.00 | 20.75 | 7.92 | 3.40 | 7.31 | 28.40 |
| SN Smith & Nephew PLC |
5.00 0.49% | 1025.00 | 53.70 | 14.27 | 1.75 | 2.26 | 2.21 | 13.21 |
| MXCT MaxCyte Inc |
5.00 1.35% | 375.00 | - | - | 10.41 | 2.15 | 6.75 | -6.5763 |
| EKF EKF Diagnostics Holdings Plc |
0.25 0.76% | 33.00 | - | - | 2.40 | 2.09 | 2.25 | -19.3996 |
| CREO Creo Medical Group PLC |
0.50 1.54% | 33.00 | - | - | 4.53 | 1.91 | 3.91 | -4.68 |
NIOX Group Plc, a diagnostics and management company, design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.
Hayakawa Building, Oxford, United Kingdom, OX4 4GB
| Name | Title | Year Born |
|---|---|---|
| Mr. Ian Roy Johnson | Exec. Chairman | 1954 |
| Mr. Michael Roy David Roller A.C.A., ACA, BA (Hons) | CFO & Director | 1965 |
| Mr. Jonathan Emms | COO & Exec. Director | NA |
| Ms. Nina Kataria | Sr. VP Global HR | NA |
| Mr. Tom Scaccia | Sr. VP of Americas & Research Bus. | NA |
| Ms. Sarah Duncan | Company Sec. | NA |
Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
UK 
AU
CA
US
NZ
Please wait processing your request...